A two-gene epigenetic signature for the prediction of response to neoadjuvant chemotherapy in triple-negative breast cancer patients

  1. Pineda, B.
  2. Diaz-Lagares, A.
  3. Pérez-Fidalgo, J.A.
  4. Burgués, O.
  5. González-Barrallo, I.
  6. Crujeiras, A.B.
  7. Sandoval, J.
  8. Esteller, M.
  9. Lluch, A.
  10. Eroles, P.
Journal:
Clinical Epigenetics

ISSN: 1868-7083,  1868-7075

Year of publication: 2019

Volume: 11

Issue: 1

Type: Article

DOI: 10.1186/S13148-019-0626-0 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

Data source: Scopus